A variant cell surface molecule associated with cancer

Details for Australian Patent Application No. 2004263514 (hide)

Owner Morphotek, Inc.

Inventors Grasso, Luigi; Nicolaides, Nicholas E.; Sass, Philip M.; Ebel, Wolfgang

Agent Peter Maxwell & Associates

Pub. Number AU-A-2004263514

PCT Pub. Number WO2005/014652

Priority 60/493,040 05.08.03 US; 60/502,715 12.09.03 US

Filing date 5 August 2004

Wipo publication date 17 February 2005

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/014652 Priority application(s): WO2005/014652

4 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263515-Condensed pyramidine compounds as inhibitors of voltage-gated ion channels

2004263512-Complexes of GPCR142 and relaxin3 or INSL5, and their production and use